A rare opportunity to acquire matured, enterprise-ready end-to-end digital health platform that integrates TelePresence AR; Hospital@Home and Remote Patient Monitoring (RPM); AI-enabled decision support, clinical documentation, translation; AR-enabled workflow
automation; AR-enhanced medical education and compliance tools; healthcare data
interoperability; connected medical, imaging, wearables and IoT devices; secure
healthcare data infrastructure; and asynchronous communication, patient chart and
scheduling.
The Telemedicine technology currently generates low-churn recurring software ARR, in addition to hardware and implementation revenue from telepresence kits, carts, smart glasses and connected clinical equipment. This demonstrates a vertically integrated digital-health model in which deployed hardware drives recurring software adoption while creating additional implementation and device revenue.
With more than 500 active clinical users and deployment experience across 43 countries.
Motivation: The owner is advancing to a new innovation venture but remains committed to supporting a multi-year transition with a qualified strategic buyer under a flexible, value-aligned deal structure aiming to accelerate platform commercialization.
An ideal acquirer for the Telemedicine technology solution will be:
- EMR Manufacturers and Vendors
- Healthcare technologyfocused private equity firms
- Hospital /Clinic network
- Individual Strategic Buyer with AI / Technology acquisition focus.
Valuation is hovering around CAD$11.4 million
Owner will welcome the best offer possible for this unique business.
June 2026 Performance Highlights:
Year-to-date June 2026 revenue: CAD$600,000+
Sale includes all proprietary IP, deployed hardware, active contracts, and the global commercial pipeline US$1-2M.
Founder and key technical staff are available for a structured transition period. Full financials, architecture, and customer details available upon NDA.
